drugset / Trial / NCT01177410
Mesalamine Granules for Irritable Bowel Syndrome (IBS) With Diarrhea
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this study is to determine the daily dose of mesalamine granules that will provide adequate relief from symptoms of IBS with diarrhea.
Timeline
- Start
- 2010-07
- Primary completion
- 2011-08
- Completion
- 2011-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Mesalamine | Small molecule | 750 mg | — |
| Subject | Mesalamine | Small molecule | 1500 mg | — |